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Abstract Estimating perceived age by facial photo-
graphs is a good estimate of health in elderly populations.
Previously, we showed that familial longevity is marked
by a more beneficial glucose metabolism already at
middle age. As glucose is also related to skin aging, this
study aimed to investigate the association between
glucose metabolism and perceived age. Perceived age
was assessed using facial photographs and non-fasted
glucose and insulin were measured in 602 subjects from
the Leiden Longevity Study. Non-diabetic subjects (n=
569) were divided in three strata according to their
glucose levels, and diabetic subjects (n=33; as a
proxy of long-term hyperglycemic exposure) were
included as a fourth stratum. Considered confounding
factors were gender, chronological age, current
smoking, body mass index, photo-damage score, and
insulin levels. Perceived age was increased from
59.6 years (SE=0.3) in the first stratum to 61.2 years
(SE=0.6) in diabetic subjects (p for trend=0.002). In
non-diabetic subjects only, perceived age was in-
creased from 59.6 years (SE=0.3) in the first stratum
to 60.6 years (SE=0.3) in the third stratum (p for
trend=0.009). Continuously, perceived age increased
0.40 years (SE=0.14, p=0.006) per 1 mmol/L
increase in glucose level in non-diabetic subjects.
The present study demonstrates that, also among non-
diabetic subjects, higher glucose levels are associated
with a higher perceived age. Future research should
be focused on elucidating possible mechanisms link-
ing glucose levels to perceived age.
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Introduction
Perceived age, or estimated age, is routinely assessed
by physicians to assess a patient's health condition.
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Perceived age was recently shown to be a robust
clinical marker for assessment of (healthy) aging.
Subjects looking old for their age had a greater risk of
both morbidity and mortality (Christensen et al.
2009). Several intrinsic and extrinsic factors have
been described to associate with perceived age. For
example, sun exposure, smoking, and low body mass
index associate with an older appearance, whereas a
high body mass index and high social class associate
with a younger appearance for one's age (Rexbye et
al. 2006). Moreover, twin studies suggest also a
genetic contribution to perceived age (Shekar et al.
2005; Gunn et al. 2009). Changes in facial features, as
skin wrinkling (Gunn et al. 2009), skin color
homogeneity (Matts et al. 2007), lip size (Gunn et
al. 2009), and sag (Ozdemir et al. 2002) have all been
linked to perceived age. However, it is largely
unknown what biological processes underlie these
facial aging features.
Glucose levels have been proposed to be a major
determinant of the aging process. Many age-related
diseases occur earlier in life, with a higher incidence
in diabetic patients compared to healthy controls
(Cerami 1985; Seshasai et al. 2011). The hypothesis
that an increased glucose level acts as an “aging
accelerator” has been supported by several research
findings in both lower model organisms and humans.
In lower model organisms, genetic alterations in the
insulin and insulin-like growth factor signaling
pathway significantly increased lifespan (Bartke
2008; Lakowski and Hekimi 1996). Long-lived
mammalian models often display higher insulin
sensitivity in conjunction with low levels of insulin
and glucose, making it difficult to disentangle the
exact contribution of each (Bartke 2008). We have
recently shown in humans, participating in the Leiden
Longevity Study, that offspring from long-lived
families, at middle age, have a lower prevalence of
diabetes and cardiovascular disease compared to
controls of comparable age (Westendorp et al.
2009). Moreover, both fasted and non-fasted glucose
levels as well as fasted insulin levels were lower in
offspring from long-lived families compared to con-
trols (Rozing et al. 2010, 2009). Offspring and
partners did not differ in the number of single
nucleotide polymorphisms associated with decreased
beta cell function (Beekman et al. 2010; Mooijaart et
al. 2011). However, using hyperinsulinemic euglyce-
mic clamp studies, we showed that the lower glucose
levels are, at least in part, explained by a higher
peripheral insulin sensitivity in the offspring group
(Wijsman et al. 2011).
Skin aging has also been linked to glucose levels.
For example, it has been shown that extensive
exposure to hyperglycemic conditions causes prema-
ture cellular senescence in human skin fibroblasts
(Blazer et al. 2002; Dekker et al. 2009). Furthermore,
diabetic patients display a higher degree of cross-links
in their collagen, which is assumed to be mainly
caused by advanced glycation end products (AGEs),
an end-stage waste product of exposure to high
glucose levels (Paul and Bailey 1996). The cross-
links in collagen prevent efficient repair, which in turn
will cause premature aging of the skin. Aging of the
skin is a major component of facial aging and is
strongly associated with perceived age (Gunn et al.
2009). Together with the potential role of glucose in
longevity, these findings have led to the hypothesis
that higher levels of non-fasted glucose, as a proxy of
higher average blood glucose during a day, may lead
to a higher perceived age. In this study, we assessed
this hypothesis by analyzing the association of non-




The Leiden Longevity Study was designed to identify
genetic and phenotypic markers related to longevity.
A total of 421 families were recruited consisting of
long-lived Caucasian siblings together with their
offspring and partners thereof. Inclusion was only
performed when at least two long-lived siblings were
still alive and fulfilled the age criteria of 89 years in
case of males and 91 years for females (Schoenmaker
et al. 2006). The siblings were not selected on health
conditions or demographics. Because proper controls
at high age are lacking, the offspring from these
nonagenarian siblings were asked to participate and
serve as cases, because they have an increased
propensity to reach an old age. The partners of the
offspring were asked to participate in the study as
controls of comparable age.
From the group of offspring and their partners, a
subpopulation of 669 participants was asked to
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participate in this cross-sectional study. As the
association between glucose and perceived age was
found to be similar in the offspring group compared
to their partners, we treated the study population as
being one. Data from the non-fasted blood samples
(glucose and insulin) were missing from 30 subjects.
Photo-damage scoring could not be determined in
male subjects with beards (n=37). Hence, in total,
602 subjects (including 33 diabetic subjects) were
used for the analyses to assess the association
between glucose levels and perceived age. Subjects
were regarded as having diabetes if they had a non-
fasted glucose level >11.0 mmol/L, a previous
medical history of diabetes, and/or used glucose-
lowering agents. The Leiden Longevity Study was
approved by the Medical Ethical Committee of the
Leiden University Medical Center, and informed
consent was obtained from all subjects.
Blood measurements
Fully automated equipment was used to perform the
serum measurements. Glucose levels were measured
with the Hitachi Modular P800 (Roche, Almere, the
Netherlands). Insulin levels were measured using
Immulite 2500 (DPC, Los Angeles, CA, USA).
Coefficients of variance of both measurements were
below 5%.
Data collection
The method for assessing a person's perceived age has
been described and validated previously (Christensen
et al. 2009; Gunn et al. 2008, 2009). In short, subjects
were asked to come to the study center without any
makeup or hairstyling products. From every partici-
pant, one photograph from the front and one at 45°
were taken. Photographs, with concealed hair and
clothing, were assessed by 60 independent assessors.
Assessors were predominately British and had no
previous age assessment experience. There was some
variation in the age and gender between the assessors.
However, it was previously shown that the assessors'
age and gender have a negligible effect on the mean
age assessment when a large number of assessors are
used (Gunn et al. 2008). The mean age assessment of
all 60 independent assessments is herein called the
perceived age. Besides determining the perceived age,
images were also assessed by two independent
dermatologists for photo-damage scoring (Griffiths
et al. 1992), in which a higher score means a higher
sun-induced damage.
Additionally, lifestyle questionnaires were sent to
the subjects to obtain insights in their smoking habits.
Weight and height, for calculating the body mass
index, were measured by research nurses at the study
center.
Statistical analyses
Body mass index was calculated by dividing weight
(in kilograms) with height (in meters) squared.
Insulin levels were not normally distributed and
therefore log transformed. In the dataset, data on
smoking were dichotomized in current smokers and
non-smokers.
For examination of the association between glu-
cose levels and perceived age, we used linear
regression models. The first two analyses were
performed in the total group (n=602) comprising the
non-diabetic subjects (n=569), divided over three
strata dependent on their glucose levels, as well as the
diabetic subjects (n=33), which were included as a
fourth stratum. First, we assessed the association
between perceived age dependent on glucose
strata in a model which was only adjusted
for gender. In a second analysis, we additionally
adjusted for body mass index, current smoking,
and photo-damage score, which were considered
confounding factors. Both analyses were repeated
in non-diabetic subjects (n=569) only, which were
divided over three strata dependent on their glucose
levels. Subsequently, we tested both in the total group
(n=602) as well as in the subgroup comprising the
non-diabetic subjects only (n=569) whether the
observed association between glucose and perceived
age was independent of insulin levels. For this, log-
transformed insulin levels were included as an
additional independent variable in the model. This
last analysis was repeated with glucose as a contin-
uous variable instead of strata to assess the influence
of 1 mmol/L increase in glucose level on perceived
age.
All statistical analyses were performed using the
SPSS program for Windows (version 17, USA). The p
values below 0.05 were considered to be statistically
significant.
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Results
Characteristics of the study population
General characteristics of the study population are
presented in Table 1. Compared to non-diabetic
subjects, diabetic subjects tended to have, on average,
a higher chronological age, a lower percentage of
females, a lower photo-damage score, and a higher
body mass index. Moreover, diabetic subjects had
higher levels of non-fasted insulin compared to non-
diabetic subjects.
Association of glucose levels and perceived age
The associations between serum glucose levels and
perceived age are presented in Table 2 and Fig. 1. The
associations between serum glucose levels and per-
ceived age were assessed in the combined group of
non-diabetic subjects, which were divided over three
strata dependent on their glucose levels and diabetic
subjects, which latter were added as a fourth stratum
as well as in the group of non-diabetic subjects only.
Analyses were performed with adjustment for gender
only, as well as with additional adjustment for
chronological age, body mass index, smoking, and
photo-damage score. The associations of the consid-
ered confounding factors with glucose levels and
perceived age are presented in supplementary Table 1.
In the combined group of diabetic and non-diabetic
subjects, using a model only adjusted for gender,
higher levels of glucose were associated with a higher
perceived age (ptrend=0.001). This association per-
sisted when the analysis was restricted to non-diabetic
subjects only (ptrend=0.001). Using a model adjusted
for chronological age, gender, body mass index,
current smoking, and photo-damage, perceived age
was increased from 59.7 years in the first stratum of
non-diabetic subjects to 61.1 years in the stratum of
the diabetic subjects (ptrend=0.003). In non-diabetic
subjects only, perceived age was increased from
59.7 years in the first stratum to 60.4 years in the
third stratum (ptrend=0.045). To test whether this
association was independent from insulin levels, the
previous model was additionally adjusted for insulin
levels. As presented in Fig. 1, the association between
glucose and perceived age persisted across the
combined group of non-diabetic and diabetic subjects,
as well is in the group of non-diabetic subjects only.
Using the fully adjusted model with glucose levels
from non-diabetic subjects as a continuous variable
instead of tertiles, the increase of perceived age per
1 mmol/L increase of glucose was approximately
0.40 years (95% CI 0.12–0.69, p=0.006). The
association of glucose levels and perceived age was
similar in males and females (results not shown).
Additionally, the association between glucose levels
and perceived age was similar for offspring from
long-lived families and their partners (results not
shown).
Discussion
The main goal of this study was to assess the
association between glucose levels and perceived
age. We showed that diabetic subjects had a tendency
toward higher perceived age compared to non-
Table 1 Characteristics of the study population
Strata of glucose levels in non-diabetic subjects Diabetic subjects
Low (N=191) Medium (N=192) High (N=186) (N=33)
Glucose range (mmol/L) 3.3–5.2 5.3–6.1 6.2–10.5 4.4–26.3
Chronological age (years) 61.8 (6.7) 63.4 (6.5) 63.4 (6.9) 64.8 (6.1)
Females, no. (%) 107 (56.0) 98 (51.0) 100 (53.8) 15 (45.5)
Photo-damage score (points) 4.51 (1.2) 4.68 (1.3) 4.84 (1.3) 4.36 (1.2)
Current smoking, no. (%) 24 (12.6) 20 (10.4) 29 (15.6) 4 (12.1)
Body mass index (kg/m2) 25.8 (3.3) 26.9 (4.1) 26.6 (4.2) 29.7 (5.2)
Ln (insulin) (mU/L) 2.44 (0.8) 2.75 (0.7) 3.31 (0.7) 3.39 (0.7)
All parameters are presented as mean with standard deviation unless indicated otherwise
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diabetic subjects. Moreover, also in non-diabetic
subjects, higher glucose levels were associated with
a higher perceived age, independent from confound-
ing factors. Taken together, these results suggest that
exposure to elevated glucose levels may indeed cause
premature aging of the skin.
The presented study has a few shortcomings to
address. The cross-sectional study design used makes
it impossible to infer a causal relationship between
glucose and perceived age. In addition, glucose levels
were measured in non-fasted samples, as a proxy of
the average serum glucose level over the day, which
could have resulted in an increased variation in the
data due to variation in time since the last meal.
However, the resulting non-differential misclassifica-
tion has probably resulted in a weaker association
between glucose levels and perceived age. Another
point to address is our earlier observation that
offspring from nonagenarian siblings displayed a
lower prevalence of type 2 diabetes and, moreover,
displayed lower levels of glucose (Rozing et al. 2010,
2009). However, we observed a similar association
between glucose and perceived age in offspring and
partners (results not shown). For this reason, we
treated these two groups as being one. Despite these
shortcomings, the significance of the results and the
robustness of the analyses support the hypothesis that
glucose level might be involved in skin aging.
Skin aging is a major component of facial aging
and is strongly associated with perceived age (Gunn
et al. 2009). Several mechanisms have been described
through which glucose could contribute to the skin
aging process. A first option is via the formation of
AGEs. An initial reaction (the Maillard reaction) of
glucose with an amino acid (e.g., lysine) forms
pentosidine, which is an AGE. This newly formed
molecule is able to react with lysine and arginine
residues on collagen molecules causing cross-links
between collagen molecules (Paul and Bailey 1996).
With an increasing concentration of AGEs in the skin,
an increasing number of cross-links are formed. This
phenomenon eventually prevents efficient collagen
repair, which in turn results in premature aging of the
skin (Avery and Bailey 2006; Paul and Bailey 1996).
Moreover, not only collagen, but also elastin, is
Table 2 Association of glucose levels and perceived age
Strata of glucose levels in non-diabetic subjects Diabetic subjects
Low (N=191) Medium (N=192) High (N=186) Ptrend
a (N=33) Ptrend
b
Perceived age (years)c 58.0 (56.9–59.1) 59.8 (58.7–60.9) 60.8 (59.6–61.9) 0.001 60.2 (57.5–62.8) 0.001
Perceived age (years)d 59.7 (59.2–60.3) 60.2 (59.6–60.8) 60.4 (59.9–61.0) 0.045 61.1 (59.9–62.3) 0.003
All presented results are means of perceived age with 95% confidence interval
aP for trends were calculated over the three strata of glucose levels in non-diabetic subjects
bP for trends were calculated over the three strata of glucose in non-diabetic subjects and diabetic subjects as a fourth stratum
cAdjusted for gender
d Adjusted for gender, chronological age, body mass index, current smoking, and photo-damage
Fig. 1 Association of glucose levels with perceived age. The
figure depicts the association between glucose level and
perceived age (n=602). Non-diabetic subjects (n=569) were
divided over tertiles of glucose and diabetic subjects (n=33)
included as a fourth category. Mean perceived age and obtained
p values were adjusted for gender, chronological age, body
mass index, current smoking, photo-damage score, and Ln
(insulin) level as described in “Methods.” For the non-diabetic
subjects, the mean perceived age (SE) was 59.6 years (0.3) in
the low, 60.2 years (0.3) in the medium, and 60.6 years (0.3) in
the high glucose tertile. For the diabetic subjects, the mean
perceived age (SE) was 61.2 years (0.6). In a model using only
the non-diabetic subjects, we observed a statistical significant
positive trend (ptrend=0.009) for the increase in perceived age
dependent on glucose tertiles. Inclusion of the diabetic subjects
in the model also revealed a highly significant positive trend
(ptrend=0.002)
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affected by AGEs, resulting in a reduction of skin
elasticity. Importantly, AGEs are not only affecting
skin tissue but also other collagenous tissues through-
out the body and as such may contribute to
cardiovascular disease (Simm et al. 2007), reduced
kidney function (Yan et al. 2007a), and vascular
complications in diabetes (Yan et al. 2007b). Because
AGEs were shown to be associated with pathological
conditions, we hypothesized that AGEs could be
inferred to the previous observed association between
perceived age and morbidities (Christensen et al.
2009). Measurements of skin fluorescence (the
formed cross-links in collagen are fluorescent) or
circulating AGEs (e.g., circulating pentosidine) could
give us more insights in whether glucose levels are
causally linked to perceived age via AGEs.
A second possibility through which serum glucose
levels may cause an older-looking appearance is the
induction of premature cellular senescence. Several
studies have shown that culturing human fibroblasts
under hyperglycemic conditions results in both an
increased amount of reactive oxygen species at a
cellular level as well as an increased induction of
premature cellular senescence (Blazer et al. 2002;
Chintapalli et al. 2007; Dekker et al. 2009). More-
over, it has been shown, by measuring p16-positive
cells, that the number of senescent cells in human skin
increases with age (Ressler et al. 2006). Histological
examination of the number of p16-positive cells or
other markers of cellular senescence could give us a
hint whether long-term exposure to, on average,
higher glucose levels might result in a higher number
of senescent cells which in turn may cause premature
skin aging and a higher perceived age.
In conclusion, our data show that higher glucose
levels were associated with higher perceived age,
independently from confounding factors. More research
has to be performed to determine whether glucose is a
causal factor behind an increased perceived age and, if
so, through which possible mechanisms (AGEs, prema-
ture induced cellular senescence, or others) glucose
could promote skin aging.
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